Logo
AI Document Review
Free
Comparison
Free
PII Redaction
Free
Pricing
Sign inSign up

AI Pharmaceutical Services Agreement Review

Backed by Microsoft For Startups
Guided by Grayver Law Group
AES-256 Encryption
Personal (PII) & Corporate Data Redacted Before AI
Free during early access

A pharmaceutical services agreement governs services between a pharma manufacturer and a contract sales organization (CSO), medical science liaison, KOL, or healthcare professional. Justee reviews pharmaceutical services agreements against the federal Anti-Kickback Statute (42 U.S.C. §1320a-7b(b)), Stark Law (42 U.S.C. §1395nn), and OIG fair-market-value safe harbors to flag fraud-and-abuse exposure.

Free and no sign-up required.

Get Your Free Document Review

Federal only

Your data is protected at every layer

No file selected

Protected by reCAPTCHA. Privacy · Terms

Guest uploads are automatically deleted within 24 hours

Key Takeaways

Anti-Kickback Statute (AKS) imposes criminal penalties for any remuneration to induce federal healthcare program referrals

Personal Services and Management Contracts safe harbor (42 CFR §1001.952(d)) requires aggregate-amount payment not based on volume/value of referrals

Stark Law applies separately to physician self-referral; safe harbors are technical and require strict compliance

1-2 minutes*

Average Review Time

195+ compliance points analyzed*

Compliance Checks

Bank-level AES-256 encryption

Document Security

* Estimates based on typical documents. Actual results vary by document type and complexity.

Pharmaceutical services agreements operate at the regulatory frontier of the federal Anti-Kickback Statute (42 U.S.C. §1320a-7b(b)), Stark Law (42 U.S.C. §1395nn), the False Claims Act (31 U.S.C. §3729), and FDA promotional standards (21 CFR §202). The AKS criminalizes any remuneration intended to induce referrals of federal healthcare-program business; OIG's 1991 personal-services safe harbor at 42 CFR §1001.952(d) provides protection only with seven specific elements (written agreement, signed by parties, term ≥1 year, schedule of services, aggregate compensation set in advance, fair-market value, services within the agreement). Stark Law's in-office ancillary and physician services exceptions add separate technical requirements. The DOJ has pursued numerous AKS prosecutions against pharma companies for speaker-program payments, "advisory boards" with no real advisory output, and consulting fees masking referral inducements (e.g., Novartis $678M settlement 2020, Insys $225M 2019). The OIG's 2020 Special Fraud Alert on speaker programs sets enforcement priorities. Justee analyzes pharmaceutical services agreements against AKS, Stark, FCA, and OIG enforcement patterns.

How It Works

1

Upload Your Document

Upload your contract in PDF, DOCX, or TXT format

2

AI Analysis

Our AI reviews your document for compliance issues

3

Review Findings

Get detailed findings with risk ratings and legal citations

4

Take Action

Use our suggestions to improve your document

What We Check

Verifies AKS personal-services safe harbor seven elements

Tests Stark Law physician self-referral exception applicability

Reviews fair-market-value compensation analysis

Validates aggregate compensation set in advance

Flags FDA promotional and PhRMA Code compliance

Common Risks We Identify

Compensation tied to volume or value of prescriptions

Aggregate amount not set in advance — AKS safe harbor lost

No FMV analysis — DOJ presumption of inducement

Speaker program structure inconsistent with OIG 2020 alert

Stark Law exception elements missing

Hypothetical Case Study by Justee

Justee recently analyzed a master speaker agreement with $4,500 per-program honoraria and 8-12 expected programs per year per speaker for a mid-cap pharma engaging 240 specialists for a $12M speaker-program over 12 months.

Issue Found: The aggregate compensation per speaker (up to $54K/year) was set per-program rather than as an aggregate amount, failing the AKS personal-services safe harbor. The OIG 2020 Special Fraud Alert on speaker programs flagged exactly this structure — high-volume speaker contracts with prescribers — as a high-risk arrangement. Several speakers were also high-prescribers of the program drug, raising direct inducement inferences. The fair-market-value analysis used a third-party benchmark from 2019 and was not refreshed.

Justee Recommendation: We restructured: (i) capped aggregate annual compensation per speaker in advance, (ii) refreshed FMV analysis with 2025 benchmarks, (iii) added speaker rotation requirements per OIG 2020 alert, (iv) eliminated programs in venues outside the OIG's "modest meal" guidance, and (v) implemented a quarterly compliance audit of speaker prescription patterns vs. honoraria.

Per-Program Compensation Without Aggregate Cap

Problematic Language

"Speaker shall be paid $4,500 per Program. Speaker is expected to deliver eight (8) to twelve (12) Programs annually."

Recommended Language

"Speaker shall be paid $[amount] per Program, with an aggregate annual compensation cap of $[fixed aggregate] per calendar year (the "Annual Cap"). The Annual Cap is set in advance in compliance with the AKS Personal Services Safe Harbor at 42 CFR §1001.952(d)(5). The number, schedule, and venue of Programs shall be determined by Sponsor based on bona fide educational need, not based on Speaker's prescribing volume or value. Speaker compensation reflects fair market value as supported by the FMV analysis dated [date] attached as Exhibit A. Sponsor shall conduct quarterly compliance reviews to confirm Programs are not concentrated among high-prescribers in violation of the OIG 2020 Special Fraud Alert on Speaker Programs."

Why it matters: AKS safe harbor requires aggregate compensation set in advance. The amended language complies and integrates OIG 2020 enforcement priorities.

No credit card required

"Justee is redefining the legal document compliance process across all practice areas, transforming hours of work into minutes, while reducing stress and boosting accuracy."

Artem Dolukhanyan
Artem Dolukhanyan

Partner, Corporate Transactions at Grayver Law Group

AI Review vs. Manual Review

FeatureJustee AI ReviewManual Review
Review Time2-5 minutes2-4 hours
CostFree trial available$150-500+
Legal CitationsAutomaticVaries by reviewer
Clause SuggestionsIncludedExtra fee
Availability24/7 instantBusiness hours
* Comparison data represents estimates based on industry research and internal testing for typical contract types. Review times, costs, and accuracy percentages vary by document complexity, length, jurisdiction, and specific legal requirements. See full disclaimer below.

Official Resources

OIG Anti-Kickback Statute

OIG AKS guidance

CMS Stark Law

CMS Stark Law resources

FDA Promotional Compliance

FDA OPDP promotional rules

Related Document Reviews

Business Associate Agreement ReviewMedical Consignment Agreement ReviewMedical Liability Waiver ReviewEngagement Letter Review
Important Legal Disclaimer

Not Legal Advice: The information and analysis provided by Justee AI is for general informational purposes only and does not constitute legal advice. While we strive to provide accurate and helpful information, our AI-powered service is not a substitute for professional legal counsel.

No Attorney-Client Relationship: Use of Justee AI does not create an attorney-client relationship. Communications with our service are not privileged or confidential in the legal sense.

Consult a Professional: For specific legal matters, we strongly recommend consulting with a qualified attorney licensed in your jurisdiction. Legal requirements vary by location and circumstances, and only a licensed attorney can provide advice tailored to your specific situation.

Performance Estimates (*): All statistics, metrics, and numerical claims on this page — including review times, cost comparisons, accuracy percentages, and database size — are estimates based on internal testing, industry research, and typical use cases. Actual results vary based on document type, complexity, length, jurisdiction, and other factors. Cost comparisons reference publicly available average attorney rates and are not guaranteed savings. "1M+ laws and regulations" refers to the breadth of Justee's reference database and does not imply that every provision is checked against every law for every document.

By using our service, you acknowledge that you have read and agree to our Terms of Use and understand the limitations of AI-powered legal analysis. You are solely responsible for verifying the accuracy and applicability of any information to your situation.

Pharmaceutical Services Agreement Review FAQ

If services involve federal healthcare program (Medicare, Medicaid) referrals, yes. Justee identifies AKS reach.

42 CFR §1001.952(d) — seven elements including aggregate compensation set in advance and FMV. Justee verifies all seven.

Third-party benchmarks (e.g., MGMA, Sullivan Cotter) refreshed annually. Justee verifies FMV analysis currency.

Yes, but with heightened scrutiny under OIG 2020 alert. Justee flags structural risks.

No. Pharma services agreements require specialized fraud-and-abuse counsel. Justee accelerates first-pass compliance review.

Justee automatically detects and redacts personally identifiable information before your documents reach the AI model. Protected types include:

Personal data:
  • Names, email addresses, and phone numbers
  • Social Security numbers and tax identifiers (ITIN)
  • Physical addresses and dates of birth
  • Credit card and bank account numbers
  • Driver's license and passport numbers
  • Medical provider identifiers (NPI) and case numbers
Corporate and business data:
  • Company and organization names
  • Business addresses and geographic locations
  • SWIFT/BIC codes, IBAN numbers, and bank routing numbers
  • Business license numbers and attorney bar IDs
  • Corporate tax identifiers (EIN)
Our system achieves 100% detection of standard PII types and approximately 97% overall coverage. Certain rare identifiers — such as cryptocurrency wallet addresses and MAC addresses — may not be detected automatically. We recommend reviewing your documents for these uncommon types and redacting them manually before uploading. See our Privacy Policy and Terms of Use for details and limitations.

Ready to Review Your Document?

Upload your document above to get started. No sign-up required.

Need more reviews? Create a free account

Last updated: May 13, 2026

Privacy

Legal

Terms of servicePrivacy policy

About

About usContactsBlogAffiliate program

Follow us

LinkedIn
logo

© 2026 Justee. All rights reserved.